Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging

BCAT1 (branched-chain amino acid trasaminase1) expression is necessary for the progression of IDH1 wild-type (WT) glioblastoma multiforme (GBM), which is known to be associated with aggressive tumors. The purpose of our study is to investigate the bevacizumab resistance increased by the expression o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hye Rim, Hong, Bora, Kim, Hyeonjin, Park, Chul-Kee, Park, Sung-Hye, Park, Sunghyouk, Choi, Seung Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342501/
https://www.ncbi.nlm.nih.gov/pubmed/27626306
http://dx.doi.org/10.18632/oncotarget.11901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342501/
https://www.ncbi.nlm.nih.gov/pubmed/27626306
http://dx.doi.org/10.18632/oncotarget.11901

Ejemplares similares